Clinical Effectiveness and Safety Study of Moxifloxacin i.v. in the Treatment of Complicated Intra-Abdominal Infection (cIAI).
Phase of Trial: Phase IV
Latest Information Update: 20 Jun 2013
At a glance
- Drugs Moxifloxacin (Primary)
- Indications Bacterial infections; Intra-abdominal infections
- Focus Therapeutic Use
- Sponsors Bayer
- 24 Jan 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
- 24 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 05 Apr 2010 New trial record